| Name | N4-[1-(4-Cyanobenzyl)-5-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-7-fluoro-2,4-quinolinedicarboxamide |
|---|---|
| Synonyms |
N-[1-(4-Cyanobenzyl)-5-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-7-fluoro-2,4-quinolinedicarboxamide
2,4-Quinolinedicarboxamide, N-[1-[(4-cyanophenyl)methyl]-5-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-7-fluoro- BAY-876 |
| Description | BAY-876 is the first highly selective GLUT1 inhibitor with IC50 of 0.002 uM. show good metabolic stability in vitro and high oral bioavailability in vivo. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 632.3±55.0 °C at 760 mmHg |
| Molecular Formula | C24H16F4N6O2 |
| Molecular Weight | 496.417 |
| Flash Point | 336.2±31.5 °C |
| Exact Mass | 496.127075 |
| LogP | 3.89 |
| Vapour Pressure | 0.0±1.9 mmHg at 25°C |
| Index of Refraction | 1.649 |
| Storage condition | -20℃ |